RBBP8 and cancer: It was reported that in BRCA1 deficient cancer cells, loss of 53BP1 leads to PARP inhibitor resistance [34, 35], therefore we checked whether the loss of 53BP1 can also cause PARP inhibitor resistance in CtIP-depleted cells.